Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer von Coutzac, Clélia, Jouniaux, Jean-Mehdi, Paci, Angelo, Schmidt, Julien, Mallardo, Domenico, Seck, Atmane, Asvatourian, Vahe, Cassard, Lydie, Saulnier, Patrick, Lacroix, Ludovic, Woerther, Paul-Louis, Vozy, Aurore, Naigeon, Marie, Nebot-Bral, Laetitia, Desbois, Mélanie, Simeone, Ester, Mateus, Christine, Boselli, Lisa, Grivel, Jonathan, Soularue, Emilie, Lepage, Patricia, Carbonnel, Franck, Ascierto, Paolo Antonio, Robert, Caroline, Chaput, Nathalie

Volltext

Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients von Carbone, Maria Luigia, Madonna, Gabriele, Capone, Alessia, Bove, Marianna, Mastroeni, Simona, Levati, Lauretta, Capone, Mariaelena, Ascierto, Paolo Antonio, De Galitiis, Federica, D’Atri, Stefania, Fortes, Cristina, Volpe, Elisabetta, Failla, Cristina Maria

Volltext

Anti-IL6R role in treatment of COVID-19-related ARDS von Buonaguro, Franco Maria, Puzanov, Igor, Ascierto, Paolo Antonio

Volltext

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma von Ascierto, Paolo Antonio, Ferrucci, Pier Francesco, Fisher, Rosalie, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V., Di Giacomo, Anna Maria, Svane, Inge Marie, Lotem, Michal, Bar-Sela, Gil, Couture, Felix, Mookerjee, Bijoyesh, Ghori, Razi, Ibrahim, Nageatte, Moreno, Blanca Homet, Ribas, Antoni

Volltext

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab von Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Madonna, Gabriele, Festino, Lucia, Grimaldi, Antonio Maria, Vanella, Vito, Simeone, Ester, Paone, Miriam, Palmieri, Giuseppe, Cavalcanti, Ernesta, Caracò, Corrado, Ascierto, Paolo Antonio

Volltext

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events von Brahmer, Julie R, Abu-Sbeih, Hamzah, Ascierto, Paolo Antonio, Brufsky, Jill, Cappelli, Laura C, Cortazar, Frank B, Gerber, David E, Hamad, Lamya, Hansen, Eric, Johnson, Douglas B, Lacouture, Mario E, Masters, Gregory A, Naidoo, Jarushka, Nanni, Michele, Perales, Miguel-Angel, Puzanov, Igor, Santomasso, Bianca D, Shanbhag, Satish P, Sharma, Rajeev, Skondra, Dimitra, Sosman, Jeffrey A, Turner, Michelle, Ernstoff, Marc S

Volltext

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy von Capone, Imerio, Marchetti, Paolo, Ascierto, Paolo Antonio, Malorni, Walter, Gabriele, Lucia

Volltext

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors von Motti, Maria Letizia, Minopoli, Michele, Di Carluccio, Gioconda, Ascierto, Paolo Antonio, Carriero, Maria Vincenza

Volltext

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice von Cortellini, Alessio, Tucci, Marco, Adamo, Vincenzo, Stucci, Luigia Stefania, Russo, Alessandro, Tanda, Enrica Teresa, Spagnolo, Francesco, Rastelli, Francesca, Bisonni, Renato, Santini, Daniele, Russano, Marco, Anesi, Cecilia, Giusti, Raffaele, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Gelibter, Alain, Occhipinti, Mario Alberto, Marconcini, Riccardo, Vitale, Maria Giuseppa, Nicolardi, Linda, Chiari, Rita, Bareggi, Claudia, Nigro, Olga, Tuzi, Alessandro, De Tursi, Michele, Petragnani, Nicola, Pala, Laura, Bracarda, Sergio, Macrini, Serena, Inno, Alessandro, Zoratto, Federica, Veltri, Enzo, Di Cocco, Barbara, Mallardo, Domenico, Vitale, Maria Grazia, Pinato, David James, Porzio, Giampiero, Ficorella, Corrado, Ascierto, Paolo Antonio

Volltext

Evolving impact of long-term survival results on metastatic melanoma treatment von Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio

Volltext

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma von Tucci, Marco, Passarelli, Anna, Mannavola, Francesco, Stucci, Luigia Stefania, Ascierto, Paolo Antonio, Capone, Marilena, Madonna, Gabriele, Lopalco, Patrizia, Silvestris, Francesco

Volltext

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma von Ferrucci, Pier Francesco, Di Giacomo, Anna Maria, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V, Stephens, Rosalie, Svane, Inge Marie, Lotem, Michal, Abu-Amna, Mahmoud, Gasal, Eduard, Ghori, Razi, Diede, Scott J, Croydon, Elizabeth S, Ribas, Antoni, Ascierto, Paolo Antonio

Volltext

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab von Morello, Silvana, Capone, Mariaelena, Sorrentino, Claudia, Giannarelli, Diana, Madonna, Gabriele, Mallardo, Domenico, Grimaldi, Antonio M, Pinto, Aldo, Ascierto, Paolo Antonio

Volltext

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy von Mallardo, Domenico, Fordellone, Mario, White, Andrew, Ottaviano, Margaret, Sparano, Francesca, Bailey, Michael, Facchini, Arianna Bianca, Ong, Sufey, Maiolino, Piera, Caracò, Corrado, Church, Sarah, Cavalcanti, Ernesta, Warren, Sarah, Budillon, Alfredo, Cesano, Alessandra, Simeone, Ester, Chiodini, Paolo, Ascierto, Paolo Antonio

Volltext

Innate Immune Cells in Melanoma: Implications for Immunotherapy von Trocchia, Marialuisa, Ventrici, Annagioia, Modestino, Luca, Cristinziano, Leonardo, Ferrara, Anne Lise, Palestra, Francesco, Loffredo, Stefania, Capone, Mariaelena, Madonna, Gabriele, Romanelli, Marilena, Ascierto, Paolo Antonio, Galdiero, Maria Rosaria

Volltext

New paradigm for stage III melanoma: from surgery to adjuvant treatment von Ascierto, Paolo Antonio, Borgognoni, Lorenzo, Botti, Gerardo, Guida, Michele, Marchetti, Paolo, Mocellin, Simone, Muto, Paolo, Palmieri, Giuseppe, Patuzzo, Roberto, Quaglino, Pietro, Stanganelli, Ignazio, Caracò, Corrado

Volltext

CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer von Cerbelli, Bruna, Botticelli, Andrea, Pisano, Annalinda, Pernazza, Angelina, Campagna, Domenico, De Luca, Alessandro, Ascierto, Paolo Antonio, Pignataro, Maria Gemma, Pelullo, Maria, Rocca, Carlo Della, Marchetti, Paolo, Fortunato, Lucio, Costarelli, Leopoldo, d’Amati, Giulia

Volltext

Management of cutaneous melanoma: radiologists challenging and risk assessment von Granata, Vincenza, Simonetti, Igino, Fusco, Roberta, Setola, Sergio Venanzio, Izzo, Francesco, Scarpato, Luigi, Vanella, Vito, Festino, Lucia, Simeone, Ester, Ascierto, Paolo Antonio, Petrillo, Antonella

Volltext

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy von Ascierto, Maria Libera, Melero, Ignacio, Ascierto, Paolo Antonio

Volltext

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program von Walker, John W, Lebbé, Celeste, Grignani, Giovanni, Nathan, Paul, Dirix, Luc, Fenig, Eyal, Ascierto, Paolo Antonio, Sandhu, Shahneen, Munhoz, Rodrigo, Benincasa, Elena, Flaskett, Sarah, Reed, Josh, Engelsberg, Arne, Hariharan, Subramanian, Kasturi, Vijay

Volltext